Open access · CC-BY
via OpenAlex
Hepatic Hamp restoration contributes to nicotinamide mononucleotide (NMN)-alleviated hepatic steatosis in chronic alcohol-fed mice
Feiwei Cao, Xinxuan Ge, Aiwen Pi, Qingling Huang, Liuhua Pei, Rucheng Chen, Wenjing Cao, Qinchao Ding, Min Yang, Qing Song, Hui Wang, Songtao Li
Communications Biology · 2026
Abstract
Hepatic nicotinamide adenine dinucleotide (NAD+) reduction is a pathological hallmark and pathogenic basis for alcohol-associated liver disease (ALD). This study investigated the therapeutic role of nicotinamide mononucleotide (NMN), a NAD+ precursor naturally presenting in various dietary sources, against ALD. Here, we show that NMN supplementation attenuates NAD+ decline, which in turn attenuates hepatic lipid deposition, dysregulated lipid metabolism genes, oxidative stress, and inflammation in ALD mice, and ultimately ameliorated liver injury. Transcriptomics-based mechanistic analysis demonstrates that alcohol-reduced hepcidin antimicrobial peptide (Hamp) is rescued by NMN, alongside the recovery of circulatory and hepatic iron levels. The hepatic Hamp expression is positively associated with NAD+ content in the liver. Hamp knockdown significantly abolishes NMN-improved lipid accumulation and the dysregulation of lipid metabolism-related genes in ethanol-treated hepatocytes. Further analysis identifies a C/EBPα-involved transcriptional regulation mechanism in NMN-protected Hamp in ALD. These findings identify NMN as a promising dietary therapeutic for ALD, acting via the C/EBPα/Hamp signaling axis. Nicotinamide mononucleotide (NMN) restores hepatic NAD+, which promotes C/EBPα-mediated Hamp transcription, thereby alleviating steatosis, oxidative stress, and inflammation in chronic alcohol-fed mice.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/s42003-026-10398-3
- Canonical
- link ↗
- Fetched
- 2026-11-14 MST
Cite this
APA
Cao, F., Ge, X., Pi, A., Huang, Q., Pei, L., Chen, R., Cao, W., Ding, Q., Yang, M., Song, Q., Wang, H., & Li, S. (2026). Hepatic Hamp restoration contributes to nicotinamide mononucleotide (NMN)-alleviated hepatic steatosis in chronic alcohol-fed mice. <em>Communications Biology</em>. https://doi.org/10.1038/s42003-026-10398-3
Vancouver
Cao F, Ge X, Pi A, Huang Q, Pei L, Chen R, et al. Hepatic Hamp restoration contributes to nicotinamide mononucleotide (NMN)-alleviated hepatic steatosis in chronic alcohol-fed mice. Communications Biology. 2026. doi:10.1038/s42003-026-10398-3.
BibTeX
@article{feiwei2026Hepati,
title = {Hepatic Hamp restoration contributes to nicotinamide mononucleotide (NMN)-alleviated hepatic steatosis in chronic alcohol-fed mice},
author = {Feiwei Cao and Xinxuan Ge and Aiwen Pi and Qingling Huang and Liuhua Pei and Rucheng Chen and Wenjing Cao and Qinchao Ding and Min Yang and Qing Song and Hui Wang and Songtao Li},
journal = {Communications Biology},
year = {2026},
doi = {10.1038/s42003-026-10398-3},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Science Advances 2025
Open access · CC-BY
Nicotinamide riboside and nicotinamide mononucleotide facilitate NAD + synthesis via enterohepatic circulation
Current Nutrition Reports 2023
Open access · OA
NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health
Redox Biology 2018
Open access · CC-BY
Nicotinamide riboside attenuates alcohol induced liver injuries via activation of SirT1/PGC-1α/mitochondrial biosynthesis pathway
Human Genomics 2019
Open access · CC-BY
Investigating RNA expression profiles altered by nicotinamide mononucleotide therapy in a chronic model of alcoholic liver disease
Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics 2020
Open access · OA
Potential significance of NAD+ biology translational research in super-aged Japan
Hepatology Communications 2026
Open access · CC-BY